Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
The International Journal of Artificial Organs|December 10, 1999
Femoral catheters: safety and efficacy in peripheral blood stem cell collectionG Adorno, F Zinno, A Bruno, et al.
Leukemia & Lymphoma|December 24, 1997
P-glycoprotein expression in de novo acute myeloid leukemiaG Del Poeta, A Venditti, G Aronica, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 3, 2016
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemiaG Del Poeta, M Postorino, L Pupo, et al.
Leukemia|July 17, 1998
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemiaA Venditti, G Del Poeta, F Buccisano, et al.
Leukemia Research|June 22, 1999
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemiaG Del Poeta, A Venditti, R Stasi, et al.
Leukemia|October 25, 2003
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantationA Venditti, L Maurillo, F Buccisano, et al.
Leukemia|July 14, 2006
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemiaF Buccisano, L Maurillo, V Gattei, et al.
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Pageof 15